Prof. Urs Fischer

Dr. Else Charlotte Sandset

Oslo, Norway
Secretary General

More Info

Urs Fischer is the “Professor for Acute Neurology and Stroke” at the University Hospital (Inselspital), Bern. He is co-chair of the Stroke Center Bern, chair of the Acute Neurological Inpatient Department and co-director of the Clinical Trial Unit (CTU), University of Bern.
He studied in Bern, London, San Francisco and Lomé and graduated in 2000. He trained as a neurologist in Bern. In 2008/2009 he performed a “Master of Science by Research in Clinical Neurology” at the University of Oxford. In 2014 he became an associate professor and in 2015 he was elected as “Professor for Acute Neurology and Stroke” at the University of Bern (Extraordinarius). He is the co-chair of the stroke center Bern and chair of the department of acute neurology. Furthermore he is co-director of the Clinical Trial Unit at the University of Bern.

Urs Fischer is a clinical researcher and his main research interest involves diagnosis, management, treatment and outcome of patients with acute neurological diseases, especially of patients with acute ischemic and hemorrhagic stroke. He is participating in multiple preventive, diagnostic and acute treatment trials and stroke registries. He is co-principal investigator of the SWITCH study (, principal investigator of the ELAN trial ( and co-principal investigator of the SWIFT DIRECT trial (

Urs Fischer is active in National and European Stroke Societies: he is Secretary General of the European Stroke Organisation (ESO), board member of the Swiss Neurological Society and he is co-founder the ESO ESMINT ESNR Stroke Winter School, which is regularly held at the University Hospital in Bern, Switzerland.

Other Executive Committee Members

Prof. Martin Dichgans

Munich, Germany

President Elect

Martin Dichgans is a Professor of Neurology at Ludwig-Maximilians-Universität, LMU (Munich, Germany). He is the Founding Director of the Institute for Stroke and Dementia Research, Director of the Interdisciplinary Stroke Center Munich, and on the Board of Directors of the DFG funded Excellence cluster ‘Munich Cluster for Systems Neurology (SyNergy)’.

Dr. Bart van der Worp

Dr. Bart van der Worp

Utrecht, Netherlands

Bart van der Worp is a neurologist with a special interest in cerebrovascular diseases at the University Medical Center in Utrecht, the Netherlands. He has been (co-)Chief Investigator of the randomised clinical trials HAMLET, PAIS, COOLIST, and VAST and is (co-)Chief Investigator of PRECIOUS (, APACHE-AF (, and MR ASAP (